Scarica l'app Stockscreener
1.41
1.44%
0.02
Dopo l'orario di chiusura:
1.43
0.02
+1.42%
Precedente Chiudi:
$1.39
Aprire:
$1.39
Volume 24 ore:
205.72K
Relative Volume:
0.48
Capitalizzazione di mercato:
$107.63M
Reddito:
$4.29M
Utile/perdita netta:
$-104.03M
Rapporto P/E:
-0.7163
EPS:
-1.9685
Flusso di cassa netto:
$-50.65M
1 W Prestazione:
-1.40%
1M Prestazione:
+9.30%
6M Prestazione:
-39.74%
1 anno Prestazione:
-9.03%
Intervallo 1D:
$1.36
$1.48
Intervallo di 1 settimana:
$1.3501
$1.51
Portata 52W:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Nome
Cibus Inc
Settore
Industria
Telefono
(858) 450-0008
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.41 | 104.57M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-19 | Ripresa | Canaccord Genuity | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Ripresa | Canaccord Genuity | Buy |
Cibus Inc Borsa (CBUS) Ultime notizie
Enterprise value to EBIT forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Enterprise value to EBITDA forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus, Inc. Class A Actuals & Estimates (NASDAQ:CBUS) - TradingView
Price to earnings forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Price to sales forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrow EPS Beat Amid Zero RevenueCFO Commentary Report - dars.gov.et
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Institutional Confidence - TradingKey
Cibus Inc (CBUS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - The Manila Times
Cibus Inc. (CBUS) Slides 1.6% as Stock Tests Key Support Near $1.17Merger Arbitrage - newsline.com
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus Resets Leadership and Board to Drive Commercialization - The Globe and Mail
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus (CBUS) Announces Leadership Changes - GuruFocus
Cibus Appoints New CEO to Drive Commercialization - Intellectia AI
Cibus appoints Craig Wichner as chief executive officer - Investing.com
Cibus, Inc. Announces Leadership Transition with Appointment of Craig Wichner as CEO - Quiver Quantitative
Farmland investor Craig Wichner becomes Cibus CEO, targets commercialization - Stock Titan
Cibus Q1 earnings call highlights - MSN
Cibus Stockholders Approve Directors and Governance Measures - The Globe and Mail
Cibus, Inc. 2026 Annual Meeting Results: Director Elections, Executive Compensation Approval, and Auditor Ratification (Form 8-K) – Minichart - Minichart
Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO - Stock Titan
Cibus (CBUS) director receives grant of 77,586 stock options - Stock Titan
Cibus (CBUS) director Moretti granted 77,586 options at $1.39 strike - Stock Titan
Stock option grant for Cibus (CBUS) director Rory B. Riggs - Stock Titan
Cibus (CBUS) director Gerhard Prante awarded 64,748 RSUs in equity grant - Stock Titan
Cibus (NASDAQ: CBUS) director awarded 64,748 RSUs in new stock grant - Stock Titan
Cibus (CBUS) director Kimberly Ann Box receives 77,586 stock options at $1.39 strike - Stock Titan
Cibus (CBUS) director Craig Wichner granted 77,586 stock options at $1.39 strike - Stock Titan
Director Urban Thomas awarded 64,748 Cibus (CBUS) shares in Form 4 filing - Stock Titan
Cibus (CBUS) upgraded to buy: What does it mean for the stock? - MSN
Cibus Inc. Q1 2026 Earnings: Smaller-Than-Expected Loss, Stock Edges LowerProduct Revenue Analysis - Město Břeclav
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus Global LLC (NASDAQ: CBUS) Share Price, CBUS Stock News, CBUS Share Price & Updates - Kalkine
CBUSCibus Inc Stock Price and Quote - Finviz
Cibus Inc. Q1 2026 Earnings: Narrowed Loss Surprises Estimates Amid Pre-Revenue ProgressEarnings Trend Analysis - The Legal Advocate
[EFFECT] Cibus, Inc. SEC Filing - Stock Titan
Cibus Inc. Q1 2026 Earnings: Narrowing Losses Amid Pre-Revenue PhaseAdjusted Earnings Analysis - The Legal Advocate
Cibus Inc Azioni (CBUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):